Ovarian cancer remains one of the most challenging malignancies to diagnose early, with symptoms often vague and undetectable until the disease has progressed significantly. However, advancements in diagnostic technologies are offering new hope for early detection and improved patient outcomes. The ovarian cancer diagnostic market is witnessing substantial growth, driven by innovations in technology, increased awareness, and a surge in research and development activities.
Market Overview
The glob